Dark Forest Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,493
Closed -$376K 1275
2024
Q4
$376K Buy
2,493
+874
+54% +$136K 0.06% 565
2024
Q3
$251K Sell
1,619
-11,882
-88% -$1.77M 0.03% 743
2024
Q2
$1.85M Buy
13,501
+11,456
+560% +$1.57M 0.34% 41
2024
Q1
$272K Buy
+2,045
New +$265K 0.05% 502
2023
Q4
Sell
-3,424
Closed -$417K 626
2023
Q3
$417K Sell
3,424
-1,024
-23% -$136K 0.03% 782
2023
Q2
$625K Buy
4,448
+3,222
+263% +$444K 0.06% 529
2023
Q1
$173K Buy
1,226
+81
+7% +$11.6K 0.04% 451
2022
Q4
$179K Buy
+1,145
New +$165K 0.04% 279
2022
Q3
Sell
-31
Closed -$4K 1202
2022
Q2
$4K Buy
+31
New +$4.22K ﹤0.01% 656
2022
Q1
Sell
-130
Closed -$22K 1380
2021
Q4
$22K Sell
130
-358
-73% -$54.5K 0.01% 658
2021
Q3
$71K Buy
+488
New +$71.4K 0.03% 474

Other funds holding DGX

Dark Forest Capital Management's DGX Position: Q1 2025 in Review

Dark Forest Capital Management sold out of Quest Diagnostics (DGX) in Q1 2025, closing a stake of 2,493 shares — an estimated $376K sold.

Dark Forest Capital Management first reported a position in DGX in Q3 2021 and held it in 11 quarters. The position peaked at $1.85M in Q2 2024. 967 funds tracked by Wall St. Rank hold DGX as of Q1 2025.

  • Dark Forest Capital Management reported no remaining Quest Diagnostics position as of Q1 2025 after selling out during the quarter.
  • Dark Forest Capital Management sold 2,493 Quest Diagnostics shares in Q1 2025, an estimated $376K.
  • Dark Forest Capital Management first reported a position in Quest Diagnostics in Q3 2021 and held it in 11 quarters.
  • Dark Forest Capital Management's Quest Diagnostics position peaked at $1.85M in Q2 2024.
  • 967 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2025.

Based on Dark Forest Capital Management's 13F filing for Q1 2025, filed 15 May 2025.